Stories

Study says pharma mergers result in fewer new medicines

Photo by Charly Triballeau/AFP/Getty Images

Pharma company mergers are reducing the number of new medicines coming to market.

That's the finding of a new working paper from Yale and London Business School researchers, who determined that 5% more drugs would become available each year if not for what they refer to as "killer acquisitions."